Generale de SanteAct Aktie
| 10,50EUR | 0,10EUR | 0,96% |
WKN: 676646 / ISIN: FR0000044471
Personal
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 33 231 | 35 875 | 34 218 | 40 278 | 40 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,13 | 0,13 | 0,15 | 0,13 | 0,13 |
Bilanz (in Mio. EUR) - Aktiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 255 | 1 366 | 1 467 | 1 304 | 1 190 |
| Summe Anlagevermögen | 5 533 | 5 592 | 5 429 | 5 535 | 5 492 |
| Summe Aktiva | 6 788 | 6 958 | 6 895 | 6 839 | 6 682 |
Bilanz (in Mio. EUR) - Passiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 5 549 | 5 681 | 5 666 | 5 657 | 5 526 |
| Summe Eigenkapital | 1 239 | 1 277 | 1 230 | 1 182 | 1 156 |
| Summe Passiva | 6 788 | 6 958 | 6 895 | 6 839 | 6 682 |
Adresse
| 39, rue Mstislav Rostropovitch, 75017 Paris | |
| Telefon | +33 (1) 87-86-23-00 |
| Internet | http://www.ramsaysante.eu |
Management
|
Anne-Marie Couderc
Independent Director |
|
Brigitte Cachon
Group Chief Impact & Sustainability officer |
|
Clément Lafaix
Group Finance Director |
|
Elvire Kodjo
Director |
|
Henrietta Rowe
Director |
|
Jamel Ouanda
Group Chief Transformation Officer |
|
Jérôme Brice
Chief Financial Officer |
|
Karen Lee Collett Penrose
Director |
|
Laurence Pinot-Lacan
Secretary, Director-Group Legal & General Counsel |
|
Magali Chessé
Director |
|
Margareta Danielus
Group Chief Medical Officer |
|
Matthieu Lance
Vice Chairman |
|
Natalie Davis
Chairman |
|
Nick Costa
Director |
|
Olivier Poher
Director |
|
Pascal Roché
Chief Executive Officer |
|
Pierre Dupérat
Group Chief Investment & Risk Officer |
|
Steven A. Sargent
Director |